BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19798749)

  • 21. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.
    Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM
    J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
    Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
    Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth-associated protein-43 is degraded via the ubiquitin-proteasome system.
    De Moliner KL; Wolfson ML; Perrone Bizzozero N; Adamo AM
    J Neurosci Res; 2005 Mar; 79(5):652-60. PubMed ID: 15668958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.
    Barmada SJ; Skibinski G; Korb E; Rao EJ; Wu JY; Finkbeiner S
    J Neurosci; 2010 Jan; 30(2):639-49. PubMed ID: 20071528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagic Modulation by Trehalose Reduces Accumulation of TDP-43 in a Cell Model of Amyotrophic Lateral Sclerosis via TFEB Activation.
    Wang Y; Liu FT; Wang YX; Guan RY; Chen C; Li DK; Bu LL; Song J; Yang YJ; Dong Y; Chen Y; Wang J
    Neurotox Res; 2018 Jul; 34(1):109-120. PubMed ID: 29383655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo.
    Watabe K; Akiyama K; Kawakami E; Ishii T; Endo K; Yanagisawa H; Sango K; Tsukamoto M
    Neuropathology; 2014 Feb; 34(1):83-98. PubMed ID: 23937386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
    Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
    Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
    Chen L; Smith L; Wang Z; Smith JB
    Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies.
    Iguchi Y; Katsuno M; Takagi S; Ishigaki S; Niwa J; Hasegawa M; Tanaka F; Sobue G
    Neurobiol Dis; 2012 Mar; 45(3):862-70. PubMed ID: 22198567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of transforming growth factor-β/Smad signaling reduces aggregate formation of mislocalized TAR DNA-binding protein-43.
    Nakamura M; Kaneko S; Ito H; Jiang S; Fujita K; Wate R; Nakano S; Fujisawa J; Kusaka H
    Neurodegener Dis; 2013; 11(4):182-93. PubMed ID: 22797246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cisplatin on proteasome activity.
    Tundo GR; Sbardella D; Ciaccio C; De Pascali S; Campanella V; Cozza P; Tarantino U; Coletta M; Fanizzi FP; Marini S
    J Inorg Biochem; 2015 Dec; 153():253-258. PubMed ID: 26387966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila.
    Uechi H; Kuranaga E; Iriki T; Takano K; Hirayama S; Miura M; Hamazaki J; Murata S
    Mol Cell Biol; 2018 Feb; 38(3):. PubMed ID: 29109084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSK3 beta-dependent phosphorylation of the alpha NAC coactivator regulates its nuclear translocation and proteasome-mediated degradation.
    Quélo I; Akhouayri O; Prud'homme J; St-Arnaud R
    Biochemistry; 2004 Mar; 43(10):2906-14. PubMed ID: 15005626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of the DYT1 mutation on torsinA oligomerization and degradation.
    Gordon KL; Gonzalez-Alegre P
    Neuroscience; 2008 Dec; 157(3):588-95. PubMed ID: 18940237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
    Osaka M; Ito D; Suzuki N
    Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of nuclear import in protection of the vitamin D receptor from polyubiquitination and proteasome-mediated degradation.
    Peleg S; Nguyen CV
    J Cell Biochem; 2010 Jul; 110(4):926-34. PubMed ID: 20564192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations.
    Chang L; Monteiro MJ
    PLoS One; 2015; 10(6):e0130162. PubMed ID: 26075709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profilin 1 mutants form aggregates that induce accumulation of prion-like TDP-43.
    Tanaka Y; Hasegawa M
    Prion; 2016 Jul; 10(4):283-9. PubMed ID: 27432186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin-proteasome pathway mediates degradation of APH-1.
    He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
    J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.